Orion Biotech Opportunities - Warrants (15/04/2025) Overview

Orion Biotech Opportunities - Warrants (15/04/2025) Selling, General & Admin

Selling, General & Admin expenses for ORIAW.

Quarterly SG&A Expenses

$203523.00

↑ 15.9% YoY

As of Dec 31, 2022

Annual SG&A Expenses (TTM)

$899674.00

↑ 62.49% YoY

Trailing 12 months ending Dec 31, 2022

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin